Xianli Meng received her PhD from the School of Pharmacy at Chengdu University of Traditional Chinese Medicine in 1998. Currently, she is committed to the interpretation of the anti-inflammatory pharmacodynamic substances and the mechanism of drugs as well as evaluating the efficacy and related mechanisms of drugs against hypoxic cardiovascular and cerebrovascular diseases using emerging imaging techniques.